National CLABSI Project Reduced ICU Infection Rate 41%
AHRQ released a final report on the national On the CUSP: Stop BSI project, which began in 2008 and was funded by AHRQ. The initiative was led by a partnership of the Health Research & Educational Trust of the American Hospital Association, the Johns Hopkins Medicine Armstrong Institute for Patient Safety and Quality and the Michigan Health & Hospital Association's Keystone Center for Patient Safety & Quality — together forming the National Project Team. The National Project Team provided education, data collection and program management to participating states.
A total of 44 states the District of Columbia, and Puerto Rico participated in the two-year program, bringing more than 1,000 hospitals and 1,800 hospital units. States could join the program in 2009, 2010 or 2011.
Through On the CUSP: Stop BSI, states reduced their adult ICU CLABSI rate from 1.915 infections per 1,000 line days to 1.133 infections — a decrease of 41 percent. In addition, by quarter six, the percentage of units with zero CLABSIs for at least one quarter reached 68 percent from a baseline of 30 percent.
These improvements are estimated to have averted 290 to 605 deaths and $36,194,850 to $40,034,450 in excess costs, based on a Centers for Disease Control & Prevention estimate of the cost per CLABSI. However, a systematic review of the cost of CLABSI indicated the cost may be higher, which would increase the savings from the project to $97,756,628 to $244,270,620, according to the report.
More Articles on the On the CUSP Project:Patient Safety Tool: CLABSI Toolkit
Patient Safety Tool: Physician Engagement Self-Diagnostic Worksheet
National Patient Safety Project Reduced CLABSI by 40%
© Copyright ASC COMMUNICATIONS 2015. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
New From Becker's Infection Control & Clinical Quality
Merck's Ebola vaccine efficacious in phase 3 study: 5 key pointsRead Now
- Dr. Julie Servoss: A GI tech must-have
- GI society roundtable: Putting together the game plan for potential colonoscopy cuts
- 5 critical steps to developing an ASC risk management program
- Researchers reconstruct ancient virus to enhance gene therapy — 5 notes
- GI physician leader to know: Dr. Jacques Van Dam of USC's Keck School Medicine